Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles vaccine + mumps vaccine + rubella vaccine (Keymen İlaç)
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
The measles, mumps, and rubella (MMR) vaccine from Keymen İlaç (a subsidiary of Alagöz Holding) is a trivalent live attenuated vaccine indicated for active immunization against measles, mumps, and rubella. As a combined vaccine, it contains weakened forms of the Measles virus, Mumps virus, and Rubella virus, which replicate minimally in the host to stimulate a robust and long-lasting immune response, including the production of neutralizing antibodies and memory B and T cells. This product is part of Keymen İlaç's extensive vaccine portfolio in Turkey, where it is approved for use in pediatric and adult populations to prevent outbreaks of these highly contagious viral diseases.
- Brand names
- Canlı Attenüe MMR Aşısı
- Other names
- MMR VaccineKızamık-Kabakulak-Kızamıkçık Aşısı
Beyond the preview
Go deeper on measles vaccine + mumps vaccine + rubella vaccine (Keymen İlaç).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles vaccine + mumps vaccine + rubella vaccine (Keymen İlaç).